Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.
DocGo Inc. (NASDAQ: DCGO) is a provider of technology-enabled mobile health and medical transportation services, and its news flow reflects this focus on out‑of‑facility care. Company press releases highlight developments in its mobile health services, remote patient monitoring, ambulance and medical transport operations, and its 50‑state virtual care network.
Investors following DocGo news can expect regular updates on financial results, including quarterly earnings announcements furnished on Form 8‑K, where the company discusses segment performance for Mobile Health Services and Transportation Services, adjusted gross margin metrics and adjusted EBITDA. These releases often include commentary from management on contract activity, care gap closure volumes, and the evolution of its payer and provider relationships.
DocGo’s news also covers contract wins and program launches, such as care gap closure programs with insurance providers, population health initiatives with public health plans and tribal and state health departments, vaccination programs with counties, and multi‑year ambulance contracts with academic medical systems and municipalities. Announcements describing longitudinal care services and transitions of care programs illustrate how the company uses mobile clinicians and telehealth to engage patients at home.
Another recurring theme in DocGo news is strategic activity and capital allocation. The company has issued releases and filed 8‑Ks regarding the acquisition of virtual care platform SteadyMD, as well as updates on its share repurchase program. In addition, DocGo frequently announces participation in healthcare and growth investor conferences, providing insight into how management presents its strategy to the market.
For anyone tracking DCGO, this news page aggregates these earnings releases, contract announcements, program launches, acquisition updates and conference appearances in one place, offering a consolidated view of the company’s operational and strategic milestones over time.
DocGo (Nasdaq: DCGO) said its virtual care division, SteadyMD, will expand clinical staff by up to 50% over the coming weeks to meet accelerating demand for clinician-led telehealth supporting branded GLP-1 weight loss care.
The hiring targets multi-state licensed clinicians (five or more active state licenses) to support nationwide delivery and onboarding is expected to begin in the next several weeks. The move aims to scale partnerships with consumer, healthcare, and digital wellness customers, including multiple Fortune 10 brands.
DocGo (Nasdaq: DCGO) announced that Chief Financial Officer Norm Rosenberg will participate in a fireside chat at the 28th Annual Needham Growth Conference on Wednesday, January 14, 2026 at 1:30 PM ET.
Rosenberg will also take part in one-on-one investor meetings. A live webcast of the fireside chat will be available on DocGo's investor relations website at https://ir.docgo.com/.
DocGo (Nasdaq: DCGO) said management will participate in three investor conferences in December 2025: Noble Capital Markets Emerging Growth Conference on December 3, Citi 2025 Global Healthcare Conference on December 4, and iAccess Alpha Best Ideas Conference on December 9–10.
CEO Lee Bienstock will deliver presentations at Noble (Dec 3 at 1:00 PM ET) and iAccess (Dec 9 at 1:00 PM ET) and will attend 1x1 meetings at all listed events. Webcasts of the two presentations will be available on DocGo's investor relations site at https://ir.docgo.com/.
DocGo (Nasdaq: DCGO) said management will participate in four investor conferences in November 2025: the 17th Annual Southwest Ideas Conference on November 19, Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum on November 20, Needham Sixth Annual Tech Week on November 21, and the BTIG Digital Health Forum on November 24.
CFO Norm Rosenberg will present at the Southwest Ideas Conference on Nov 19 at 2:20 PM ET with a webcast available on DocGo’s investor relations site. CEO Lee Bienstock and CFO Norm Rosenberg are scheduled for 1x1 meetings at the Canaccord and Needham events. CEO Bienstock will join a BTIG panel on Care Gap Closure and Mobile Health Support at 11:00 AM ET on Nov 24.
DocGo (Nasdaq: DCGO) reported third quarter 2025 results with total revenue $70.8M, down from $138.7M a year ago due to the wind-down of migrant-related programs.
Excluding migrant-related revenue, core revenue rose 8% to $62.4M. GAAP gross margin was 20.0% and adjusted gross margin was 33.0%. Net loss was $29.7M, which included $16.7M of non-cash impairments. Adjusted EBITDA loss was $7.2M. Cash and equivalents were $95.2M as of Sept 30, 2025, after repaying a $30M line of credit; operating cash flow was $1.7M for the quarter.
Company reported record volumes across major lines (transportation +2.5%, care gap +320%, phlebotomy +11%, RPM +6%), completed the acquisition of SteadyMD, and provided 2025 and 2026 guidance: 2025 revenue $315–320M (including $68–70M migrant revenue) and adjusted EBITDA loss $25–28M; 2026 revenue $280–300M with adjusted EBITDA loss $15–25M.
DocGo (Nasdaq: DCGO) announced a partnership with a California health plan to launch Longitudinal Care Services targeting 10,000 under‑engaged plan members. The program combines on‑site mobile clinicians and telehealth to deliver preventive care, chronic care management and transitions of care, with clinicians using connected diagnostic equipment supervised by virtual advanced practice providers. The expansion with a current partner is expected to launch in Q4 2025 and aims to address care gaps that drive ER use and worsening chronic conditions.
The company highlighted its 50‑state virtual care platform, mobile health and ambulance services as supporting capabilities and included a forward‑looking disclaimer about risks and uncertainties.
DocGo (Nasdaq: DCGO) will release third quarter 2025 results for the period ended September 30, 2025 after market close on Monday, November 10, 2025.
Management will host a conference call and webcast the same day at 5:00 p.m. ET. Dial-in numbers: 1-800-717-1738 (U.S.) and 1-646-307-1865 (international); Conference ID: 87106. A webcast will be available under Events in the Investors section at https://ir.docgo.com/. The release covers Q3 2025 financial results and a management discussion on performance and outlook.
DocGo (Nasdaq: DCGO) announced the acquisition of virtual care platform SteadyMD, combining DocGo’s mobile health and medical transportation services with SteadyMD’s 50-state telehealth platform.
Key disclosed metrics: SteadyMD is expected to service ~3 million patients in 2025, maintain a roster of > 600 clinicians, and generate approximately $25 million revenue in 2025; SteadyMD is expected to be EBITDA positive in 2026. DocGo plans to fund the transaction from existing cash and will update 2025 revenue and adjusted EBITDA guidance in early November. SteadyMD founders are joining DocGo leadership.
DocGo (Nasdaq: DCGO), a technology-enabled mobile health and medical transportation services provider, has announced its participation in three upcoming investor conferences.
The company will participate in the Three Part Advisors Midwest on August 26th, where CFO Norm Rosenberg will present at 11:30 AM CT. CEO Lee Bienstock will attend the Cantor Global Healthcare Conference on September 3rd at 10:20 AM ET and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10th at 9:15 AM ET. All events will include 1x1 meetings and webcasts available on DocGo's investor relations website.
DocGo (Nasdaq: DCGO) reported Q2 2025 financial results, with total revenue of $80.4 million, down from $164.9 million in Q2 2024, primarily due to planned wind-down of migrant-related programs. The company posted a net loss of $13.3 million and Adjusted EBITDA loss of $6.1 million.
Key highlights include increased total cash balance to $128.7 million, surpassing 1.2 million patients assigned for care gap closure services, and expansion of healthcare partnerships. The company maintained its 2025 guidance of $300-$330 million in revenue and adjusted EBITDA loss of $20-$30 million. DocGo implemented cost-cutting measures, targeting $10 million in annual savings, and expects to achieve profitability in H2 2026.
The company continues expanding its payer and provider business, launching new care gap closure programs and medical transportation services across multiple states.
FAQ
What is the current stock price of DOCGO (DCGO)?
What is the market cap of DOCGO (DCGO)?
